European Medicines Agency re-org
This article was originally published in The Tan Sheet
Executive Summary
A major re-organization of the EU agency streamlines human drug pre- and post-authorization activities into one unit, creates a patient health protection unit and designates a group to manage product data and documentation, the agency announces Dec. 8. The changes respond to increased responsibilities proposed in legislation, the agency said. The regulator, which dropped its acronym EMEA because the second "e" confused stakeholders, plans to launch in early 2010 a redesigned Web site with improved search and navigation functions